Latham Honoured With Five EMEA LMG Life Sciences Awards

LMG Life Sciences

May 13, 2022

Latham & Watkins was honoured with five awards at the 2022 Europe LMG Life Sciences Awards. Regarded as one of the industry’s top programs, the prestigious annual awards recognise leading law firms and lawyers from across the region to celebrate their success in the life sciences industry.

The firm earned recognition in five key categories for the second consecutive year, including Corporate Firm of the Year, M&A Firm of the Year, Belgium Firm of the Year, and Germany Firm of the Year. LMG Life Sciences also recognised Latham in the Impact Case of the Year category for securing a significant victory for Antonin Cohen before the French Court of Appeals of Aix-en-Provence concerning the marketing of CBD products.

Latham was shortlisted in various other categories, including Competition and Antitrust Firm of the Year, France Firm of the Year, Italy Firm of the Year, Scandinavian Firm of the Year, and UK Firm of the Year. London partners Robbie McLaren and Frances Stocks Allen were also commended as finalists for M&A Lawyer of the Year and Regulatory Rising Star, respectively.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.